The E5 oncoprotein of BPV-4 does not interfere with the biosynthetic pathway of non-classical MHC class I

Virology

Volumn 353, Issue 1, 2006, Pages 174-183

  Araibi, E H ^a   Marchetti, B ^a   Dornan, E S ^a   Ashrafi, G H ^a   Dobromylskyj, M ^b   Ellis, S A ^b   Campo, M S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

BPV; Classical MHC class I; E5; E5 MHC class I interaction; MHC class I down regulation; Non classical MHC class I

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; PROTEIN E5; PROTEIN SUBUNIT; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACIDIFICATION; ANIMAL CELL; ARTICLE; CELL DEATH; CELL SURFACE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DOWN REGULATION; GOLGI COMPLEX; HEAVY CHAIN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION;

ANIMALS; BOVINE PAPILLOMAVIRUS 1; BOVINE PAPILLOMAVIRUS 4; CATTLE; CELL LINE, TUMOR; HISTOCOMPATIBILITY ANTIGENS CLASS I; MASTOCYTOMA; MICE; ONCOGENE PROTEINS, VIRAL;

BOVINE PAPILLOMAVIRUS - 4; BOVINE PARVOVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; MAMMALIA;

EID: 33747874274     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.05.031     Document Type: Article

References (32)

1. Anderson R.A., Scobie L., O'Neil B.W., Grindlay G.J., and Campo M.S. Viral proteins of bovine papillomavirus type 4 during the development of alimentary canal tumours. Veterin. J. 154 (1997) 69-78
2. Araibi E.H., Marchetti B., Ashrafi G.H., and Campo M.S. Down-regulation of MHC class I in bovine papillomas. J. Gen. Virol. 85 (2004) 2809-2814
3. Ashrafi G.H., Pitts J.D., Faccini A., McLean P., O'Brien V., Finbow M.E., and Campo S. Binding of bovine papillomavirus type 4 E8 to ductin (16 K proteolipid), down-regulation of gap junction intercellular communication and full cell transformation are independent events. J. Gen. Virol. 81 (2000) 689-694
4. Ashrafi G.H., Tsirimonaki E., Marchetti B., O'Brien P.M., Sibbet G.J., Andrew L., and Campo M.S. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21 (2002) 248-259
5. Ashrafi G.H., Haghshenas M.R., Marchetti B., O'Brien P.M., and Campo M.S. The E5 protein of human papillomavirus type 16 selectively down-regulates surface HLA class. Int. J. Cancer 113 (2005) 276-283
6. Ashrafi, G.H., Haghshenas, M.R., Marchetti, B., Campo, M.S., in press. E5 protein of Human Papillomavirus 16 down-regulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int. J. Cancer.
7. Borrego F., Masilamani M., Kabat J., Sanni T.B., and Coligan J.E. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor. Mol. Immunol. 42 (2005) 485-488
8. Cohen G., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., and Baltimore D. The selective down-regulation of class I MHC complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10 (1999) 661-671
9. Davies C.J., Hill J.R., Edwards J.L., Schrick F.N., Fisher P.J., Eldridge J.A., and Schlafer D.H. Major histocompatibility antigen expression on the bovine placenta: its relationship to abnormal pregnancies and retained placenta. Anim. Reprod. Sci. 82-83 (2004) 267-280
10. Di Palma F., Archibald S.D., Young J.R., and Ellis S.A. A BAC contig of approximately 400 kb contains the classical class I major histocompatibility complex (MHC) genes of cattle. Eur. J. Immunogenet. 29 (2002) 65-68
11. Ellis S.A., Staines K.A., and Morrison W.I. cDNA sequence of cattle MHC class I genes transcribed in serologically defined haplotypes A18 and A31. Immunogenetics 43 (1996) 156-159
12. Ellis S.A., Holmes E.C., Staines K.A., Smith K.B., Stear M.J., McKeever D.J., MacHugh N.D., and Morrison W.I. Variation in the number of expressed MHC genes in different cattle class I haplotypes. Immunogenetics 50 (1999) 319-328
13. Ellis S.A., Morrison W.I., MacHugh N.D., Birch J., Burrells A., and Stear M.J. Serological and molecular diversity in the cattle MHC class I region. Immunogenetics 57 (2005) 601-606
14. Frazer I.H., Thomas R., Zhou J., Leggatt G., Dunn L., McMillan N., Tindle R.W., Filgueira L., Manders P., Barnard P., and Sharkey M. Potential strategies utilised by papillomavirus to evade host immunity. Immunol. Rev. 168 (1999) 131-142
15. Geraghty D.E., Koller B.H., and Orr H.T. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc. Natl. Acad. Sci. 84 (1987) 9145-9149
16. Hofmeister V., and Weiss E.H. HLA-G modulates immune responses by diverse receptor interactions. Semin. Cancer Biol. 13 (2003) 317-323
17. Marchetti B., Ashrafi G.H., Tsirimonaki E., O'Brien P.M.A., and Campo M.S. The papillomavirus oncoprotein E5 retains the major histocompatibility class I in the Golgi apparatus and prevents its transport to the cell surface. Oncogene 21 (2002) 7808-7816
18. Marchetti B., Ashrafi G.H., Araibi E.H., Ellis S.A., and Campo M.S. The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus. Oncogene 27 (2006) 2254-2263
19. McQueen K.L., and Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr. Opin. Immunol. 14 (2002) 615-621
20. O'Brien P.M., and Campo M.S. Evasion of host immunity directed by papillomavirus-encoded proteins. Virus Res. 1-2 (2002) 103-118
21. Pennie W.D., Grindlay G.J., Cairney M., and Campo M.S. Analysis of the transforming functions of bovine papillomavirus type 4. Virology 193 (1993) 614-620
22. Piguet V. Receptor modulation in viral replication: HIV, HSV, HHV-8 and HPV: same goal, different techniques to interfere with MHC-I antigen presentation. Curr. Top. Microbiol. Immunol. 285 (2005) 199-217
23. Pizzato N., Derrien M., and Lenfant F. The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation. Hum. Immunol. 65 (2004) 1389-1396
24. Riteau B., Moreau P., Menier C., Khalil-Daher I., Khosrotehrani K., Bras-Goncalves R., Paul P., Dausset J., Rouas-Freiss N., and Carosella E.D. Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line. Transplant. Proc. 33 (2001) 2360-2364
25. Roeth J.F., Williams M., Kasper M.R., Filzen T.M., and Collins K.L. HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J. Cell. Biol. 167 (2004) 903-913
26. Storset A.K., Slettedal I.O., Williams J.L., Law A., and Dissen E. Natural killer cell receptors in cattle: a bovine killer cell immunoglobulin-like receptor multigene family contains members with divergent signaling motifs. Eur. J. Immunol. 33 (2003) 980-990
27. Storset A.K., Kulberg S., Berg I., Boysen P., Hope J.C., and Dissen E. NKp46 defines a subset of bovine leukocytes with natural killer cell characteristics. Eur. J. Immunol. 34 (2004) 669-676
28. Tindle R. Immune evasion in human papillomavirus-associated cervical cancer. Nat. Rev., Cancer 2 (2002) 59-65
29. Tomasec P., Braud V.M., Rickards C., Powell M.B., McSharry B.P., Gadola S., Cerundolo V., Borysiewicz L.K., McMichael A.J., and Wilkinson G.W. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287 (2000) 1031-1033
30. Toye P.G., MacHugh N.D., Bensaid A.M., Alberti S., Teale A.J., and Morrison W.I. Transfection into mouse L cells of genes encoding two serologically and functionally distinct bovine class I MHC molecules from a MHC-homozygous animal: evidence for a second class I locus in cattle. Immunology 70 (1990) 20-26
31. Wang E., McSharry B., Retiere C., Tomasec P., Williams S., Borysiewicz L.K., Braud V.M., and Wilkinson G.W. UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 7570-7575
32. Williams M., Roeth J.F., Kasper M.R., Fleis R.I., Przybycin C.G., and Collins K.L. Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. J. Virol. 76 (2002) 12173-12184